UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Sleep and circadian biomarkers of postoperative delirium (SLEEP-POD): protocol for a prospective and observational cohort study

BMJ open, 2024-04, Vol.14 (4), p.e080796-e080796

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of Rest-Activity Rhythm and Risk of Developing Dementia or Mild Cognitive Impairment in the Middle-Aged and Older Population: Prospective Cohort Study

JMIR public health and surveillance, 2024-05, Vol.10, p.e55211

2024

Link zum Volltext

Verfügbarkeit prüfen

Novel Benzodiazepine Photoaffinity Probe Stereoselectively Labels a Site Deep within the Membrane-Spanning Domain of the Cholecystokinin Receptor

Journal of medicinal chemistry, 2006-02, Vol.49 (3), p.850-863

2006

Link zum Volltext

Verfügbarkeit prüfen

1020 ◻Rest-activity Rhythm Linked to Parkinsonism in Older Adults: Results from the Rush Memory and Aging Project

Sleep (New York, N.Y.), 2024-04, Vol.47 (Supplement_1), p.A438-A439

2024

Link zum Volltext

Verfügbarkeit prüfen

1017 Healthy Sleep, Healthy Mind: Examining the Relationship Between Objective Sleep Measures and Delirium Development

Sleep (New York, N.Y.), 2024-04, Vol.47 (Supplement_1), p.A437-A437

2024

Link zum Volltext

Verfügbarkeit prüfen

Biarylaniline Phenethanolamines as Potent and Selective β3 Adrenergic Receptor Agonists

Journal of medicinal chemistry, 2006-05, Vol.49 (9), p.2758-2771

2006

Link zum Volltext

Verfügbarkeit prüfen

Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke

The New England journal of medicine, 2023-02, Vol.388 (5), p.478-479

2023

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Evaluation of Potent and Selective β3 Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres

Journal of medicinal chemistry, 2002-01, Vol.45 (3), p.567-583

2002

Link zum Volltext

Verfügbarkeit prüfen

Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Journal of medicinal chemistry, 1997-08, Vol.40 (17), p.2706-2725

1997

Link zum Volltext

Verfügbarkeit prüfen

Intermolecular Interactions between Peptidic and Nonpeptidic Agonists and the Third Extracellular Loop of the Cholecystokinin 1 Receptor

Journal of medicinal chemistry, 2003-07, Vol.46 (16), p.3476-3482

2003

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

Journal of medicinal chemistry, 1996-01, Vol.39 (2), p.562-569

1996

Link zum Volltext

Verfügbarkeit prüfen

1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists

Bioorganic & medicinal chemistry letters, 2001-05, Vol.11 (9), p.1145-1148

2001

Link zum Volltext

Verfügbarkeit prüfen

Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels

Biochemistry (Easton), 1993-03, Vol.32 (9), p.2363-2370

1993

Link zum Volltext

Verfügbarkeit prüfen

An Improved Synthesis and Resolution of 3-Amino-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-ones

Journal of organic chemistry, 1995-02, Vol.60 (3), p.730-734

1995

Link zum Volltext

Verfügbarkeit prüfen

3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.3030-3034

1996

Link zum Volltext

Verfügbarkeit prüfen

3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents

Journal of medicinal chemistry, 1996-07, Vol.39 (14), p.2655-2658

1996

Link zum Volltext

Verfügbarkeit prüfen

CCK-A Receptor Selective Antagonists Derived from the CCK-A Receptor Selective Tetrapeptide Agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623)

Journal of medicinal chemistry, 1995-01, Vol.38 (1), p.207-211

1995

Link zum Volltext

Verfügbarkeit prüfen

Conversion of acyclic nonpeptide CCK antagonists into CCK agonists

Bioorganic & medicinal chemistry letters, 1997-03, Vol.7 (5), p.511-514

1997

Link zum Volltext

Verfügbarkeit prüfen

Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands

Journal of medicinal chemistry, 1995-08, Vol.38 (17), p.3384-3390

1995

Link zum Volltext

Verfügbarkeit prüfen

Influence of pseudoallylic strain on the conformational preference of 4-methyl-4-phenylpipecolic acid derivatives

Journal of organic chemistry, 1985-12, Vol.50 (25), p.5032-5037

1985

Link zum Volltext

Verfügbarkeit prüfen

Determination of the three-dimensional structure of iberiotoxin in solution by proton nuclear magnetic resonance spectroscopy

Biochemistry (Easton), 1992-09, Vol.31 (35), p.8151-8159

1992

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres

Journal of medicinal chemistry, 2002-01, Vol.45 (3), p.567-583

2002

Link zum Volltext

Verfügbarkeit prüfen

Cyclic lactam analogs of Ac-[Nle4].alpha.-MSH4-11-NH2

Biochemistry (Easton), 1988-10, Vol.27 (21), p.8181-8188

1988

Link zum Volltext

Verfügbarkeit prüfen

Allele-specific activation of genetically engineered receptors

The Journal of biological chemistry, 1991-01, Vol.266 (1), p.5-8

1991

Link zum Volltext

Verfügbarkeit prüfen

Stereochemical studies on medicinal agents. 30. Investigation of 4-(3-hydroxyphenyl)-4-methylpipecolic acid as a conformationally restricted mimic of the tyrosyl residue of leucine-enkephalinamide

Journal of medicinal chemistry, 1986-10, Vol.29 (10), p.2028-2033

1986

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Sleep and circadian biomarkers of postoperative delirium (SLEEP-POD): protocol for a prospective and observational cohort study

Association of Rest-Activity Rhythm and Risk of Developing Dementia or Mild Cognitive Impairment in the Middle-Aged and Older Population: Prospective Cohort Study

Novel Benzodiazepine Photoaffinity Probe Stereoselectively Labels a Site Deep within the Membrane-Spanning Domain of the Cholecystokinin Receptor

1020 ◻Rest-activity Rhythm Linked to Parkinsonism in Older Adults: Results from the Rush Memory and Aging Project

1017 Healthy Sleep, Healthy Mind: Examining the Relationship Between Objective Sleep Measures and Delirium Development

Biarylaniline Phenethanolamines as Potent and Selective β3 Adrenergic Receptor Agonists

Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke

Synthesis and Evaluation of Potent and Selective β3 Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres

Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Intermolecular Interactions between Peptidic and Nonpeptidic Agonists and the Third Extracellular Loop of the Cholecystokinin 1 Receptor

Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists

Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels

An Improved Synthesis and Resolution of 3-Amino-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-ones

3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists

3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents

CCK-A Receptor Selective Antagonists Derived from the CCK-A Receptor Selective Tetrapeptide Agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623)

Conversion of acyclic nonpeptide CCK antagonists into CCK agonists

Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands

Influence of pseudoallylic strain on the conformational preference of 4-methyl-4-phenylpipecolic acid derivatives

Determination of the three-dimensional structure of iberiotoxin in solution by proton nuclear magnetic resonance spectroscopy

Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres

Cyclic lactam analogs of Ac-[Nle4].alpha.-MSH4-11-NH2

Allele-specific activation of genetically engineered receptors

Stereochemical studies on medicinal agents. 30. Investigation of 4-(3-hydroxyphenyl)-4-methylpipecolic acid as a conformationally restricted mimic of the tyrosyl residue of leucine-enkephalinamide

Suchergebnisse filtern